Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells.
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesInhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodiesMolecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainJC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathyThe expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT proteinAssociation of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNABk virus: a clinical reviewImproved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapyProgressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab.Progressive multifocal leukoencephalopathy in HIV-1 infection.Cortical and subcortical JC virus infection: two unusual cases of AIDS associated progressive multifocal leukoencephalopathyPrimate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virionsDetection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformationRearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rateThe rapidly expanding family of human polyomaviruses: recent developments in understanding their life cycle and role in human pathology.Molecular biology and immunoregulation of human neurotropic JC virus in CNS.Multiple roles for Puralpha in cellular and viral regulation.JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals.Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy.Differential expression of mRNAs for JC virus large and small tumor antigens in brain tissues from progressive multifocal leukoencephalopathy patients with and without AIDS.Simian virus 40-induced disease in rhesus monkeys with simian acquired immunodeficiency syndromeJC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy.Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.Human demyelinating disease and the polyomavirus JCV.TAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat proteinHuman JC virus perfect palindromic nuclear factor 1-binding sequences important for glial cell-specific expression in differentiating embryonal carcinoma cells.The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression.A novel sequence-specific DNA-binding protein, LCP-1, interacts with single-stranded DNA and differentially regulates early gene expression of the human neurotropic JC virus.Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokinesEvidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat.Human cytomegalovirus induces JC virus DNA replication in human fibroblasts.Genetic regulation of human immunodeficiency virus.Regulation of gene expression in primate polyomaviruses.Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytomaImmune surveillance and response to JC virus infection and PML.Progressive multifocal leukoencephalopathy: what's new?Tits and bits of HIV Tat protein.Pathogenesis of progressive multifocal leukoencephalopathy--revisitedThe human JC polyomavirus (JCPyV): virological background and clinical implications.
P2860
Q21285083-968BBF3C-8B9A-4259-BC52-48B45D99D483Q24568329-CAA41136-3313-46E0-9A6A-B830D5C1139BQ24619923-86149B57-D343-4115-8532-C6D9BBAFA40FQ24643911-681D2AE9-21C6-4FF2-98EC-893A89AC3A08Q24680024-E0837224-7575-48D7-9654-7D067384ACF2Q24684911-9AE4D543-D7FD-4F9D-A8AC-5835FCC2310DQ28203015-B7211934-037C-43EC-B19F-7D5E76104E91Q28478894-CE50B39C-8899-46B2-9B70-F441965C43F6Q30354301-FB9C9023-8827-4668-8E45-61E6A314EF32Q33506561-931B9C97-E33A-4F22-9899-CF22E7896777Q33732964-B1A67AD8-7DD4-4FA5-ABEF-2182BDF5B907Q33851781-71751624-C1C0-4024-B2BD-14D426426B63Q33945721-F8EB074C-3CF3-4890-B52A-57ED2F8372E0Q34178250-3A07CA1A-803B-4A22-B47B-FA5FD08DC700Q34629128-901F687C-E5AE-4592-A297-5D6648273E3FQ34638628-BDE52875-2547-4DC8-93DE-30D8353B321EQ34934006-10259389-47EB-44DE-9E0F-7B57B9D22ACCQ35005863-8053D8B4-92FB-4D31-980D-AF3C70732539Q35225109-FA760F34-4BD5-4D49-991F-170B99ABB0D7Q35452693-6DE6BB6E-C6F1-43F3-9232-C4CEBA510FC5Q35692942-F925CC44-940D-45C3-ADC4-B5FC3E127A96Q35831779-FBE26EDB-3842-4993-B708-88DFEBED0142Q35899152-BAEC0C95-88D6-4450-91A2-F40AFAF91521Q36171859-6F201022-AF71-42BF-94F5-6AFB6F6C08C6Q36455705-F6D544BA-468E-4505-B208-E283AE370191Q36639281-D89E6852-DCAF-4B07-BCEC-5644EA90A28EQ36640328-A7CDBFE9-D8AA-40EA-ACFE-B172D10175CAQ36649447-A510BF69-D5CB-45CD-ACE5-450DDF72C0F1Q36686311-92EE28B4-4AB6-4C6E-A0A5-DEE0DEBA3DEEQ36687077-C176F09D-8620-4B7A-9ECA-361B7D157ACDQ36687332-D9009B68-10A9-415B-B533-F05AE2A30B0AQ36704007-D5D924B2-F957-466A-A7BD-7049F5D5CB3DQ37056955-5BA058D2-116D-4AD1-8999-CDCC4908A47EQ37410842-CC55AC37-91E8-4AA9-8528-7C0D32325AFAQ37504261-C819494E-2D03-4447-B2C4-D84877047FEFQ37678580-1EAE1128-0DDF-4A38-84F7-5C8D84541509Q37755922-655B7D1B-47A9-4963-90B6-309B6C7111CFQ37825906-E419F11B-0006-4CB7-B74C-86EE5B177F5EQ37828002-3AEFA189-DCD9-4282-AAEF-CE7039D386D4Q38115572-93159D10-949B-4574-B0E3-28F36AECCC77
P2860
Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells.
description
1990 nî lūn-bûn
@nan
1990 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Trans-activation of the JC vir ...... ficiency virus in glial cells.
@ast
Trans-activation of the JC vir ...... ficiency virus in glial cells.
@en
Trans-activation of the JC vir ...... ficiency virus in glial cells.
@nl
type
label
Trans-activation of the JC vir ...... ficiency virus in glial cells.
@ast
Trans-activation of the JC vir ...... ficiency virus in glial cells.
@en
Trans-activation of the JC vir ...... ficiency virus in glial cells.
@nl
prefLabel
Trans-activation of the JC vir ...... ficiency virus in glial cells.
@ast
Trans-activation of the JC vir ...... ficiency virus in glial cells.
@en
Trans-activation of the JC vir ...... ficiency virus in glial cells.
@nl
P2093
P2860
P356
P1476
Trans-activation of the JC vir ...... ficiency virus in glial cells.
@en
P2093
P2860
P304
P356
10.1073/PNAS.87.9.3479
P407
P577
1990-05-01T00:00:00Z